38 extractive question-and-answer pairs built from 1768823342 cardiology 1-5, published by icmr.gov.in. The source is a 1-page publication. Source-evidenced topics include stemi, thrombolysis, aspirin, clopidogrel, atorvastatin, rosuvastatin, dual antiplatelets, unfractionated heparin. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. Question types in the export: 34 factual, 1 comparison, 1 definition, 1 list, 1 relationship. 4 of the 38 pairs (10.5%) ask explanatory questions; the remaining 34 are factual or table-based questions. 94.74% of rows pass the corpus quality gate.
This dataset contains 38 extractive question-and-answer pairs derived from a cardiology-focused publication by the Indian Council of Medical Research (ICMR). The questions cover topics such as STEMI protocols, thrombolysis, anticoagulants, and lipid-lowering agents. Each answer is a verbatim excerpt from the source document, ensuring traceability. The dataset includes factual, comparison, definition, list, and relationship-based questions, with 94.74% of rows meeting quality standards. The source material is a single-page document, and all rows are validated for accuracy.
Browse more economy datasets, including other records from the same source when available.
Explore Economy datasets1725952331_psychiatry_all - Question and Answer Dataset
Economy · 176 rows
ICMR Standard Treatment Workflow (STW) SUPRACONDYLAR FRACTURE OF HUMERUS IN CHILDREN - Question and Answer Dataset
Economy · 22 rows
1726569102_ophthalmology_all - Question and Answer Dataset
Health · 77 rows
1725952349_ent - Question and Answer Dataset
Health · 178 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1K+ rows
Higher Education in India - Question and Answer Dataset
Economy · 1.5K+ rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1.1K+ rows
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/www-icmr-gov-in-a3022e084856ada4f3df85e6c589d093/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("www-icmr-gov-in-a3022e084856ada4f3df85e6c589d093")
df.head()First 10 of 38 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_document | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| What is the classification for angina that worsens to CCS class III? | crescendo | 1. Angina at rest or lasting more than 20 minutes 2. Recent worsening of stable angina (crescendo) to CCS class III 3. New onset effort angina of less than 1 month in CCS class II/ III 4. Post infarction angina ECG: If ST Elevation: Follow ST Elevation MI (STEMI) protocol If no ST Elavation: UA/NSTEMI | 88 | definition | 0.940 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Recent worsening of stable angina (crescendo) to CCS class III 3. | 1 | page=1,block=88 | 0.700 | valid |
| What is the preferred anticoagulant to continue until PCI or discharge after thrombolysis? | Enoxaparin (preferred over unfractionated heparin) | POST THROMBOLYSIS 1. ECG to be done at 60-90 min after starting thrombolysis to assess whether thrombolysis is successful ( >50% ST settlement with pain relief) or not 2. If successful, transfer patient for PCI within 3-24 hours 3. If thrombolysis failed, transfer patient immediately for PCI capable hospital 4. Enoxaparin (preferred over unfractionated heparin) to be continued till PCI OR discharge THROMBOLYSE 1. Within 12 hours of symptom onset, if no contra-indication 2. Preferably with fibrin specific agent Tenecteplase/ TPA/ Reteplase or Streptokinase, if fibrin-specific are unavailable 3. Therapy to be started within 10 min preferably B. If Transfer to PCI incapable hospital not feasible | 313 | comparison | 0.920 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | If thrombolysis failed, transfer patient immediately for PCI capable hospital 4. Enoxaparin (preferred over unfractionated heparin) to be continued till PCI OR discharge THROMBOLYSE 1. | 1 | page=1,block=117 | 0.700 | |
| What symptom is commonly associated with diffuse retrosternal pain, heaviness, or constriction? | Associated with sweating | • Diffuse retrosternal pain, heaviness or constriction • Radiation to arms or neck or back • Associated with sweating • Easily reproduced with post-meal exertion • Consider atypical presentation: Exertional fatigue or breathlessness or profuse sweating or epigastric discomfort/ syncope More likelihood if known patient of CAD/ multiple risk factors Variable location or characteristic Long lasting (hours to days) or short lasting (less than a minute) Restricted to areas above jaw or below epigatrium Localized to a point Precipitated by movement of neck or arms or respiration | 93 | relationship | 0.890 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | • Diffuse retrosternal pain, heaviness or constriction • Radiation to arms or neck or back • Associated with sweating • Easily reproduced with post-meal exertion • Consider atypical presentation: Exertional fatigue or breathlessness or profuse sweating or epigastric discomfort/ syncope More likelihood if known patient of CAD/ multiple risk factors Variable location or characteristic Long lasting (hours to days) or short lasting (less than a minute) Restricted to areas above jaw or below epigatrium Localized to a point Precipitated by movement of neck or arms or respiration | ||||
| What is the preferred type of agent for thrombolysis? | fibrin specific agent Tenecteplase/ TPA/ Reteplase | POST THROMBOLYSIS 1. ECG to be done at 60-90 min after starting thrombolysis to assess whether thrombolysis is successful ( >50% ST settlement with pain relief) or not 2. If successful, transfer patient for PCI within 3-24 hours 3. If thrombolysis failed, transfer patient immediately for PCI capable hospital 4. Enoxaparin (preferred over unfractionated heparin) to be continued till PCI OR discharge THROMBOLYSE 1. Within 12 hours of symptom onset, if no contra-indication 2. Preferably with fibrin specific agent Tenecteplase/ TPA/ Reteplase or Streptokinase, if fibrin-specific are unavailable 3. Therapy to be started within 10 min preferably B. If Transfer to PCI incapable hospital not feasible | 494 | list | 0.820 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Preferably with fibrin specific agent Tenecteplase/ TPA/ Reteplase or Streptokinase, if fibrin-specific are unavailable 3. | 1 | page=1,block=117 | 0.700 | valid |
| What condition requires immediate transfer to a PCI-capable hospital? | ongoing pain, thrombolysis and transfer immediately | Transfer to PCI capable hospital immediately Angiography with a view to PCI only if any of following/ Contra indications of angiography: If ongoing pain, thrombolysis and transfer immediately Recurrent anginal pain not controlled by medical therapy Cardiogenic shock Acute LVF Mecahnical complication Dynamic ST-T changes Life threatening ventricular arrhythmias | 140 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Transfer to PCI capable hospital immediately Angiography with a view to PCI only if any of following/ Contra indications of angiography: If ongoing pain, thrombolysis and transfer immediately Recurrent anginal pain not controlled by medical therapy Cardiogenic shock Acute LVF Mecahnical complication Dynamic ST-T changes Life threatening ventricular arrhythmias | 1 | page=1,block=8 | 0.700 | valid |
| What is a contraindication for angiography related to recent trauma? | Recent (within 1 month) major trauma/ surgey/ head injury | Previous intra- cerebral hemorrhage or stroke of unknown etiology Ischemic stroke in last 6 months CNS neoplasm or AV malformation Recent (within 1 month) major trauma/ surgey/ head injury Recent (within 1 month) major GI bleed Known bleeding tendency (except menstrual bleed) Aortic dissection Severe uncontrolled hypertension Standard Treatment Workflow (STW) ST ELEVATION MYOCARDIAL INFARCTION (STEMI) | 131 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Previous intra- cerebral hemorrhage or stroke of unknown etiology Ischemic stroke in last 6 months CNS neoplasm or AV malformation Recent (within 1 month) major trauma/ surgey/ head injury Recent (within 1 month) major GI bleed Known bleeding tendency (except menstrual bleed) Aortic dissection Severe uncontrolled hypertension Standard Treatment Workflow (STW) ST ELEVATION MYOCARDIAL INFARCTION (STEMI) | 1 | page=1,block=18 | 0.700 | valid |
| What is the dose range for Ramipril in ACE-inhibitor therapy? | Ramipril 2.5 -10 mg OD | Anti-platelets 1. Aspirin: Loading dose 325 mg followed by 75 mg OD 2. Clopidogrel: Loading dose 300 mg followed 75 mg OD 3. Prasugrel: Loading dose 60 mg followed by 10 mg OD 4. Ticagralor: Loading dose 180 mg followed by 90 mg BD Anti-ischemic: Metoprolol: Short acting: 25-100 mg BD Long acting: 25 -100 mg OD Nitrates: Isosorbide mono-nitare 20 to 60 mg in 2 divided dose Nitroglycerine sustained release 2.6 to 6.5 mg BD Nitroglycerine IV 5-25 mcg/ min infusion Lipid lowering agents: High dose Atorvastatin 80 mg OD Rosuvastatin 20-40mg OD Non-statin lipid modifying agents Ace-inhibitor Ramipril 2.5 -10 mg OD Enalapril 2.5 -10mg BD Oxygen: If oxygen saturation below 90% Morphine: Titrated in a dose of 2-4 mg IV every 15 minutes Beta-blocker: Oral beta-blocker if LVEF is less than 40% Anti thrombotics: 1. | 594 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Ticagralor: Loading dose 180 mg followed by 90 mg BD Anti-ischemic: Metoprolol: Short acting: 25-100 mg BD Long acting: 25 -100 mg OD Nitrates: Isosorbide mono-nitare 20 to 60 mg in 2 divided dose Nitroglycerine sustained release 2.6 to 6.5 mg BD Nitroglycerine IV 5-25 mcg/ min infusion Lipid lowering agents: High dose Atorvastatin 80 mg OD Rosuvastatin 20-40mg OD Non-statin lipid modifying agents Ace-inhibitor Ramipril 2.5 -10 mg OD Enalapril 2.5 -10mg BD Oxygen: If oxygen saturation below 90% Morphine: Titrated in a dose of 2-4 mg IV every 15 minutes Beta-blocker: Oral beta-blocker if LVEF | ||||
| What is the protocol to follow if ST elevation is observed on an ECG? | Follow ST Elevation MI (STEMI) protocol | 1. Angina at rest or lasting more than 20 minutes 2. Recent worsening of stable angina (crescendo) to CCS class III 3. New onset effort angina of less than 1 month in CCS class II/ III 4. Post infarction angina ECG: If ST Elevation: Follow ST Elevation MI (STEMI) protocol If no ST Elavation: UA/NSTEMI | 233 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Post infarction angina ECG: If ST Elevation: Follow ST Elevation MI (STEMI) protocol If no ST Elavation: UA/NSTEMI | 1 | page=1,block=88 | 0.700 | valid |
| What is the recommended action if PCI is possible within 120 minutes at a non-primary PCI capable center? | Immediate transfer to PCI centre | Primary-PCI capable centre EMS or non primary-PCI capable centre PCI possible <120 mins? Yes No Yes No Primary PCI Rescue PCI Preferably <60 mins Preferably 3-24 hours Preferabl y within 30 mins Preferably <90mins (<60 mins) in early presenters Immediate transfer to PCI centre Immediately Immediate transfer to PCI centre Successful fibrinolysis Immediate fibrinolysis | 245 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Primary-PCI capable centre EMS or non primary-PCI capable centre PCI possible <120 mins? Yes No Yes No Primary PCI Rescue PCI Preferably <60 mins Preferably 3-24 hours Preferabl y within 30 mins Preferably <90mins (<60 mins) in early presenters Immediate transfer to PCI centre Immediately Immediate transfer to PCI centre Successful fibrinolysis Immediate fibrinolysis | 1 | page=1,block=57 | 0.700 | valid |
| What is the recommended dose of enoxaparin for administration every 12 hours? | 1 mg/Kg SC 12 hrly | Unfractionated heparin: Bolus of 60 U/Kg (maximum 5000 U) followed by 12 U/Kg hourly infusion to maintain APTT at 50-70 sec 2. Enoxaparin: 1 mg/Kg SC 12 hrly Thrombolyic Therapy: Tenecteplase 35 mg IV bolus if 60-70 Kg 40 mg IV bolus if 70-80 Kg 45 mg IV bolus if more than 80 Kg Reteplase | 139 | factual | 0.570 | https://www.icmr.gov.in/icmrobject/uploads/STWs/1768823342_cardiology_1-5.pdf | Enoxaparin: 1 mg/Kg SC 12 hrly Thrombolyic Therapy: Tenecteplase 35 mg IV bolus if 60-70 Kg 40 mg IV bolus if 70-80 Kg 45 mg IV bolus if more than 80 Kg Reteplase | 1 | page=1,block=36 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| valid |
| 1 |
| page=1,block=91 |
| 0.700 |
| valid |
| 1 |
| page=1,block=36 |
| 0.700 |
| valid |